Apex Biotechnology Corp. (TPE:1733)
Taiwan · Delayed Price · Currency is TWD 29.40
-0.15 (-0.51%)
Jan 21, 2026, 1:30 PM CST
Apex Biotechnology Market Cap
Apex Biotechnology has a market cap or net worth of 2.94 billion as of January 21, 2026. Its market cap has decreased by -2.81% in one year.
Market Cap
2.94B
Enterprise Value
2.49B
Revenue
1.96B
Ranking
n/a
PE Ratio
19.60
Stock Price
29.40
Market Cap Chart
Since September 7, 2001, Apex Biotechnology's market cap has increased from 1.43B to 2.94B, an increase of 106.21%. That is a compound annual growth rate of 3.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 2.95B | -2.96% |
| Dec 31, 2025 | 3.04B | 1.16% |
| Dec 31, 2024 | 3.01B | -25.31% |
| Dec 29, 2023 | 4.03B | 57.73% |
| Dec 30, 2022 | 2.55B | -1.73% |
| Dec 30, 2021 | 2.60B | 10.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 263.50B |
| PharmaEssentia | 217.10B |
| Lotus Pharmaceutical | 88.76B |
| Bora Pharmaceuticals Co., LTD. | 67.84B |
| Heron Neutron Medical | 67.13B |
| Oneness Biotech | 33.73B |
| Center Laboratories | 31.50B |
| Lumosa Therapeutics | 31.25B |